Results 121 to 130 of about 11,369 (213)

Supplementary Figure 1 from The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer

open access: yes, 2006
Supplementary Figure 1 from The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian ...
Kosei Hasegawa (42141)   +8 more
core   +1 more source

Supplementary Fig. S1 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

open access: yes, 2009
Supplementary Fig. S1 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung ...
Shinji Kuroda (197818)   +8 more
core   +1 more source

Supplementary Fig. S2 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

open access: yes, 2009
Supplementary Fig. S2 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung ...
Shinji Kuroda (197818)   +8 more
core   +1 more source

Supplementary Figure Legends 1-4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer

open access: yes, 2010
Supplementary Figure Legends 1-4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...
Yasuo Urata (157765)   +9 more
core   +1 more source

Lytic cycle: A defining process in oncolytic virotherapy

open access: yes, 2013
The viral lytic cycle is an important process in oncolytic virotherapy. Most mathematical models for oncolytic virotherapy do not incorporate this process.
Wang, Yujie   +2 more
core   +1 more source

Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context

open access: yesEClinicalMedicine
Summary: Background: Oncolytic virotherapy (OV) is an innovative immunotherapy strategy. A comprehensive understanding of oncolytic viruses is essential for advancing research and clinical practice.
Poyee Lau   +4 more
doaj   +1 more source

Supplementary Fig. S4 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

open access: yes, 2009
Supplementary Fig. S4 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung ...
Shinji Kuroda (197818)   +8 more
core   +1 more source

Current Development of Virotherapy in Breast Cancer: A Brief Review

open access: yesActa Medica Bulgarica
Breast cancer is the cancer with the greatest incidence in the world by 2020. This cancer has a high mortality rate, has the capability of metastasizing, and causes damage to important organs of the human body.
Sasmana I.   +4 more
doaj   +1 more source

The 16th international oncolytic virotherapy conference: from in vitro to clinical studies, novel approaches in cancer therapy meeting report

open access: yes
The 16th International Oncolytic Virotherapy Conference, which was held in the vibrant city of Rotterdam, Netherlands, on 27-30th November 2024, featured a variety of novel strategies for improving oncolytic virus therapy.
Othman, Eman M.   +3 more
core   +1 more source

Oncolytic Virotherapy with the Focus to Pancreatic Ductal Adenocarcinoma Therapy

open access: yes
Bakalářská práce se zaměřuje na problematiku nádorových onemocnění, jejich výskyt, průběh a léčbu. Práce také poskytuje stručný přehled o alternativním způsobu léčby rakoviny - onkolytické viroterapii.
Kulyk, Veronika
core   +1 more source

Home - About - Disclaimer - Privacy